November 9, 2026 · Anesthesiology · DOI: 10.1097/ALN.0000000000006467

Intravenous Lidocaine in Liver Surgery ‒ A Randomized Double-Blind Trial.

Listen to this summary

This randomized, double-blind trial of 124 patients undergoing minor liver surgery asked whether perioperative intravenous lidocaine (1.5 mg/kg bolus plus 1.5 mg/kg/h infusion) reduces postoperative opioid use compared with placebo. Lidocaine did not significantly lower 24-hour opioid consumption (83 vs. 97 mg oral morphine equivalents, p=0.429), though it produced lower pain scores at early time points that did not persist into postoperative day 1. Adverse events were similar between groups, and plasma lidocaine levels, though transiently elevated in two patients after the bolus, stayed at non-toxic concentrations, so the authors concluded that IV lidocaine is safe but offers no meaningful opioid-sparing benefit in this setting.

Emil Östrand, Jenny Rystedt, Ingrid Östlund, Thomas Kander, Bodil Andersson, Bobby Tingstedt

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play